Suven Life Sciences’ will be presenting its portfolio of investigational neuroscience new chemical entities (NCEs) at Alzheimer’s Association International Conference (AAIC) being held in Copenhagen, Denmark during July 12-17, 2014.
AAIC is the world’s largest conference of its kind, where thousands of researchers from more than 60 countries will gather to reveal the latest study results, theories and discoveries bringing the world closer to breakthroughs in dementia science.
Suven Life Science is a biopharmaceutical company focused on discovering, developing and commercializing novel pharmaceutical products, which are first in class or best in class CNS therapies through the use of GPCR targets.
